Randomized, Crossover, Pharmacodynamic Study Comparing the Effects of Two Proton Pump Inhibitors.
Phase of Trial: Phase III
Latest Information Update: 19 Mar 2015
At a glance
- Drugs Omeprazole/sodium bicarbonate (Primary) ; Lansoprazole
- Indications Erosive oesophagitis; Gastro-oesophageal reflux; Heartburn; Peptic ulcer
- Focus Pharmacodynamics
- Sponsors Bayer; Merck Sharp & Dohme; Schering-Plough
- 03 Feb 2010 Planned end date changed from 1 Dec 2009 to 1 Jan 2010 as reported by ClinicalTrials.gov.
- 03 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Nov 2009 New trial record